Ampleforth (AMPL) experienced a rapid price increase of 15.38% within five minutes on October 19, rising from $1.17 to $1.35. This spike marked the high point of its 24-hour trading range and was accompanied by increased trading volume. Over the full 24-hour period, AMPL gained 12.59%, indicating the brief surge was stronger than the overall daily gain. The token's market capitalization was about $2.64 million at the time, with total 24-hour volume reaching $34,249. This sharp movement highlights heightened interest and volatility in AMPL trading on that day.
Ampleforth's rapid price surge on October 19 provides context for cryptocurrency market activity. For readers following crypto broadly, here is Pluang's market snapshot as of Oct 20, 2026 03:42 WIB: 46 out of 50 major cryptocurrencies rose today. Notable movers include XTZ at Rp5.408 with a 5.17% gain and 100% buy order activity, LTC at Rp1.074.528 up 5.12%, and GRT at Rp428 with a 4.93% rise.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
